LAUSR

available at http://www.ncbi.nlm.nih.gov/pubmed/30426256 Editorial Comment: The authors report a single surgeon, prospective, randomized study of traditional robotic radical prostatectomy using a Retzius sparing technique in 102 consecutive patients. Continence was defined as 0 pads per day. Consistent with other studies, the immediate continence rate is superior with the Retzius sparing technique (51% vs 21%). The advantage persisted at 3 and 6 months following surgery. Positive margin rates were higher in the Retzius sparing group. Jeffrey A. Cadeddu, MD Suggested Reading Menon M, Dalela D, Jamil M et al: Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches. J Urol 2018; 199: 1210. Re: Robot-Assisted Radical Prostatectomy after Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence L. Marconi, T. Stonier, R. Tourinho-Barbosa, C. Moore, H. U. Ahmed, X. Cathelineau, M. Emberton, R. Sanchez-Salas and P. Cathcart Urology Centre, Guy’s and St. Thomas NHS Foundation Trust, Department of Urology, Kings College Hospital, Department of Urology, University College London Hospitals, Imperial College Healthcare NHS Trust, Imperial College London, and Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, United Kingdom, and Department of Urology, Institut Mutualiste Montsouris, Universit e ParisDescartes, Paris, France Eur Urol 2019; 76: 27e30. doi: 10.1016/j.eururo.2019.03.007 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/30426256 Editorial Comment: The authors report their multicenter experience with salvage robotic prostatectomy in men with local recurrence following focal therapy. Technically the outcomes are comparable to primary robotic prostatectomy series with no major intraoperative or postoperative complications, a 13% positive margin rate and a 12-month continence rate of 83%. What is disconcerting, however, is that the biochemical progression-free survival rates were 74%, 48% and 36% at 1, 2 and 3 years following surgery, respectively. For this primarily intermediate risk cohort these results raise concern when compared to expected outcomes for primary robotic prostatectomy for intermediate risk prostate cancer. Jeffrey A. Cadeddu, MD LAPAROSCOPY/NEW TECHNOLOGY 233 Copyright © 20 American Urological Association Education and Research Inc Unauthorized reproduction of this article is prohibite 20